News

Researchers at Michigan Medicine and the Cleveland Clinic believe a newly designed blood test will help people with irritable ...
Study reveals how a new IgE antibody therapy reactivates immune cells, offering a promising approach to fighting ovarian ...
The global antibody discovery market size is anticipated to reach approximately USD 22,570 million by 2034, up from USD 9,570 ...
Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.
With an arsenal of antibody assets based on IgE, IgA, and IgG, the newly combined company has opportunities across cancer indications.
Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
In many cases, what seems like weight gain might be inflammation-driven swelling and not additional fat. Identifying and ...
Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.
The combined company will clinically advance Epsilogen's MOv18 IgE antibody in ovarian cancer and TigaTx's anti-EGFR IgA antibody.
IgG antibodies are commonly used in cancer treatment. They help the body's immune system fight cancer and are being ...
The data presented support use of MR vaccine at 6 months to protect young infants during measles outbreaks and in settings with increased risk or high transmission. We recommend additional studies to ...
Last week, as my recent lab results loaded into the patient portal, my fears came true: “No significant level of detectable measles IgG antibody.” My heart sank as I read the words.